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ABSTRACT
Substance use is a risk behavior that tends to increase during adolescence, a time
when part of the personality is still in development. Traditionally, personality
psychopathology has been measured in terms of categories, although dimensional
models have demonstrated better consistency. This study aimed to analyze
differences in personality profiles between adolescents with substance use disorders
(SUD n = 74) and matched community controls (MCC n = 74) using the
Personality Psychopathology Five (PSY-5) dimensional model. Additionally, we
compared age at first drug use, level of drug use and internalizing and externalizing
symptoms between the groups. In this study, the PSY-5 model has proved to be
useful for differentiating specific personality disturbances in adolescents with
SUD and community adolescents. The Disconstraint scale was particularly useful
for discriminating adolescents with substance use problems and the Delinquent
Attitudes facet offered the best differentiation.
Subjects Psychiatry and Psychology
Keywords Personality psychopathology five (PSY-5), Dimensional, Substance use disorders,
Internalizing–externalizing symptoms, Adolescents
INTRODUCTION
Substance use disorders (SUD) are complex entities with multiple biological and
environmental risk factors and a wide range of clinical expressions (Hicks, Iacono &
McGue, 2014). Their study requires detailed evaluation across several dimensions of
substance use and related problems, in addition to an assessment of quantity and frequency
of drug use (Kaminer, 2008). One of these dimensions is psychopathological personality
traits. Many studies have identified behavioral disinhibition and emotional dysregulation
as important factors in the etiology of SUD (Baker et al., 2004; Iacono, Malone & McGue,
2008; Tarter et al., 2003), and different personality traits predict distinct patterns of
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substance use (Castellanos-Ryan, O’Leary-Barrett & Conrod, 2013; Elkins et al., 2006).
The links between personality dimensions and substance behavior appear to be mediated
by different reinforcement processes (Woicik et al., 2009). Evidence demonstrates that
personality traits can be used as endophenotypes of the risk for SUD, building a bridge
between genes and SUD, allowing better understanding of which individual differences
provide vulnerability (Belcher et al., 2014).
The Personality Psychopathology Five (PSY-5) is a descriptive, dimensional model
of personality. It was initially developed with the Minnesota Multiphasic Personality
Inventory-2 (MMPI-2) by Harkness (1992), to complement the categorical diagnosis of
personality disorders in adults, and was later adapted for use with adolescents (MMPI-A;
McNulty et al., 1997). The model comprises five broad dimensional scales: Aggressiveness,
Psychoticism, Disconstraint, Introversion, and Neuroticism or Negative Emotionality
(Harkness et al., 2012).
The Aggressiveness scale relates to anger and rage (Harkness, 2009) and aggression used
to accomplish goals or intimidate others. High scores on this scale are associated with
antagonism, dominance, aggressive tendencies, and ambition, as well as with externalizing
subtypes of post-traumatic stress disorder (i.e., Miller et al., 2004). The Aggressiveness scale
has two facets: Hostility and Grandiosity/Indignation. The Psychoticism scale measures
disconnection from reality with alienation and distrustfulness, and high scores are
significant predictors of schizotypal or borderline symptoms with a history of suicide
attempts. The Psychoticism scale contains two facets: Psychotic Beliefs/Experiences
and Odd Mentation. The Disconstraint scale assesses the extent to which behavior is
constrained by consideration of future consequences (Harkness, 2009), and high scores
correlate with other personality characteristics such as impulsivity, sensation seeking, and
boredom proneness (Harkness et al., 2012). The Disconstraint scale comprises two facets:
Delinquent Attitudes and Norm Violation. The Introversion scale, measures the extent
to which respondents are inward-looking and focused on internal thoughts, feelings, and
moods. High scores are related to low sociability, low energy, and low positive emotions.
The Introversion scale is composed by the facets of Low Drive/Expectations and Low
Sociability. Finally, the Negative Emotionality scale is considered as a single facet and
refers to the sensitivity of the danger detection system and anxiety (i.e., to danger cues). It
correlates with harm avoidance, behavioral inhibition, and emotional instability (Harkness
et al., 2012). These neurotic personality traits have shown be linked to drinking behavior
through a negative reinforcement processes, and linked to the ability of some substances to
relieve negative affective states (Woicik et al., 2009).
Most literature on the PSY-5 model has concerned adult populations, and relatively few
studies have been conducted with adolescents. Among those that have been conducted
with adolescents, the study by McNulty et al. (1997) is noteworthy for describing the
adaptation of scales to the adolescent population based on the MMPI-A. Bolinskey et
al. (2004) subsequently developed the specific facets for the PSY-5 scales. More recent
studies include those by Veltri et al. (2009) and Veltri et al. (2014) with forensic adolescent
samples, which found that the Disconstraint scale is a marker of behavioral disinhibition
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and impulsivity and is associated with nonviolent delinquency, whereas Aggressiveness
is characterized by the use of instrumental aggression and interpersonal dominance. In
a general adolescent clinical population, Stokes et al. (2009) provided support for the
predictive validity of the MMPI-A PSY-5 facet scales, finding that most demonstrate good
to excellent internal consistency. Moreover, found that externalizing problems were related
most strongly and consistently to the Aggressiveness and the Disconstraint scales, and
internalizing problems and symptoms were related to the Negative Emotionality and
the Introversion scales. However, not all PSY-5 scales have been fully studied and their
usefulness in community control and SUD adolescents has not been compared.
The Disconstraint and Negative Emotionality from the PSY-5 scales seem to capture
aspects that are important in the etiology of addictive behaviors (Elkins et al., 2006). High
scores on the Disconstraint scale are indicative of behavioral under-control or neurobe-
havioral disinhibition, which are associated with both earlier onset of heavy substance
use and a greater persistence of alcohol use and abuse (Chassin, Pitts & Prost, 2002), and
prospectively predict substance-related disorders (Caspi et al., 1996). Tarter et al. (2003)
also indicated that neurobehavioral disinhibition is a component of the liability to early age
at onset of SUD. On the other hand, high scores on the Negative Emotionality scale are as-
sociated with the maintenance of SUD through negative reinforcement (Baker et al., 2004).
In addition to personality characteristics, several emotional and behavioral problems
are also commonly associated with substance use in adolescence. Externalizing problems
at an early age are associated with later substance use; these problems regularly precede
adolescent substance use in both genders. In women, adolescent cannabis and alcohol
use predict internalizing disorders in adulthood (Miettunen et al., 2014). Behavioral
disinhibition is associated with a higher familial loading, earlier age of initiation,
adolescent onset of SUD and a more severe and persistent course of SUD in adulthood
(Hicks, Iacono & McGue, 2014). Although the associations are weaker and less consistent,
there is also evidence of an internalizing pathway to SUD (Hussong et al., 2011). In
adolescents this liability is expressed through a lack of approach and exploratory behavior,
passivity, discomfort, shyness and anxiety (Hicks, Iacono & McGue, 2014).
The primary aim of this study was to examine the association between PSY-5 scales
(and their facets) and drug use patterns (age at onset and level of drug use) in a group of
adolescents with SUD and matched community controls (MCC). The secondary aim was
to compare the PSY-5 scales (adolescent report) with the broadband scales of internalizing
and externalizing symptoms from the Child Behavior Checklist (CBCL; parents report) in
both groups.
The study tested the following hypotheses. First, the PSY-5 scales, especially Dis-
constraint, would be able to differentiate substance use patterns between SUD cases
and MCC. Second, SUD cases would score higher on the Disconstraint and Negative
Emotionality scales than community adolescents. Third, early age at onset of drug use
would be associated with higher scores on the Disconstraint scale. Fourth, the PSY-5
scales, Negative Emotionality, would be associated with mixed internalizing/externalizing
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symptoms, Introversion with internalizing symptoms, and Aggressiveness or Disconstraint
with externalizing symptoms from the CBCL.
METHOD
Participants
Substance use disorder (SUD) group
The study was conducted in a Child and Adolescent Psychiatry Department of a tertiary
hospital in Spain. One hundred and twelve patients were referred for treatment for SUD
to the Addictive Behaviors Unit of the Child and Adolescent Psychiatry and Psychology
Service of a public hospital, of whom 93 (83%) agreed to participate. Among these, 11
did not complete the assessment protocol and 9 were younger than the control group age
range. This left a final group of 74 adolescents aged 15–18 years who met the criteria for
SUD (for alcohol, cannabis or other drugs excluding tobacco) as defined in the Diagnostic
and Statistical Manual of Mental Disorders, Fourth Edition Text Revision (DSM-IV-TR;
American Psychiatric Association, 2002). Patients were evaluated by two professionals (a
clinical psychologist and a psychiatrist) who both have extensive clinical experience and are
specialists in dual disorders in adolescents.
Matched community control (MCC) group
We tried to match the SUD group, according to gender, age and academic level, with
74 adolescents from five secondary schools, with no prior psychological or psychiatric
diagnosis or treatment. Finally, control subjects were matched according to the gender,
taking into account a window of age between +/−6 months with respect to the
corresponding SUD subject. The participating schools were selected by means of stratified
random sampling in the metropolitan area of Barcelona (divided into five areas according
to zip code). Of an initial group of 425 adolescents within the same SUD patients age
range (aged 15–18 years), 247 did not provide informed consent to participate in the study,
a further 17 failed to attend on the day of assessment, and 44 either did not complete
the assessment protocol or reported a history of psychological or psychiatric treatment.
From the remaining pool of 117 controls who did complete the protocol, a final group
of 74 subjects was matched with the SUD cases. The procedure for discarding subjects
with previous psychological treatment was as follows: first, professors were asked orally to
preselect subjects who, in their view, did not present mental problems. Participants (and
parents) were then asked in a self-report format whether they (or their children) had been
previously treated for, or diagnosed with, psychological or psychiatric disorders. Subjects
who answered affirmatively were excluded from the analysis.
Measures
Sociodemographic data
A short screening questionnaire was applied to the MCC group in order to obtain data on
age, gender, schooling, and so on. In the case of SUD patients, these data were obtained
from clinical records.
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Psychiatric diagnosis
Both SUD and other clinical diagnoses were extracted from the hospital data processing
system and verified personally with the clinicians who also reported any changes in the
patient’s status. Initial diagnoses of the clinical sample were based on the Spanish version of
the Kiddie-SADS semi-structured diagnostic interview for children and adolescents. This
instrument has shown good reliability and validity for present and life-time disorders.
Substance use
Information regarding age at onset of drug use and the level of use, in terms of the
quantity/frequency of the different drugs used, was gathered through semi-structured
interviews adapted to Spanish (Dı´az et al., 2008) from those used in the Collaborative
Study on Genetics of Alcoholism (Hesselbrock et al., 1999).
The level of use of each drug (tobacco, alcohol, cannabis, cocaine, amphetamine
derivatives, etc.) was coded by the clinician according to pattern of frequency and
characteristics of use into three ordinal categories: (1) No use; (2) Substance use
without problems (i.e., drug use at parties, during holidays, or at special celebrations,
with no evidence of drug-related problems); and (3) Risky substance use, defined as a
quantity-frequency and/or situational pattern of drug use that could lead to health or
psychosocial problems in adolescents. This category includes diagnoses of drug abuse or
dependence, only presents in the SUD patients group. In the MCC group only occasional
alcohol intoxication at parties, more than 4 alcohol units per occasion or weekend use
of cannabis were accepted; other patterns of use were considered as exclusion criteria.
Participants were classified by the clinical staff according to their reported substance use
patterns. In doubtful cases, a consensus was obtained among several clinicians.
Personality psychopathology
The Spanish version of the MMPI-A, which shows acceptable psychometric properties
(Jime´nez-Go´mez & A´vila-Espada, 2003), was administered. This self-report contains 478
items assessing personality characteristics and psychopathological symptoms in adoles-
cents. The PSY-5 scales were extracted through an algorithm based on item configuration
obtained from the model adapted by Bolinskey et al. (2004). This model contains five broad
clinical scales that are reorganized into facets that help to identify those content areas
responsible for clinical elevations on the corresponding PSY-5 scale. The model shows
good psychometric properties, with a moderate to high index of reliability (Cronbach’s
alpha from 0.79 to 0.83 for the domains, and from 0.57 to 0.78 for the facets) (Bolinskey
et al., 2004; Archer, 2005). For the present study, the Cronbach’s alphas were from 0.74 to
0.84 for the domains and from 0.52 to 0.80 for the facets. The inter-correlations among
PSY-5 scales in the present study ranged between .09 (Introversion-Aggressiveness) to .54
(Disconstraint-Aggressiveness).
Behavioral and emotional symptoms
A Spanish version of the original Child Behavior Checklist (CBCL) (Achenbach, 1991)
was completed by parents to assess behavioral symptoms among adolescents. The CBCL
comprises eight narrow-band scales (Anxious/Depressed, Withdrawn/Depressed, Somatic
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Complaints, Social Problems, Thought Problems, Attention Problems, Rule-Breaking
Behavior, and Aggressive Behavior) and two broad-band scales (Internalizing and
Externalizing), and has demonstrated moderate internal consistency and good test-retest
reliability (Albores-Gallo et al., 2007). For the present analysis, only T scores for the
internalizing and externalizing scales were used. T scores above 70 were considered
clinically significant. For the present study, the Cronbach’s alphas were 0.88 for the
internalizing scale and 0.81 for the externalizing scale. Data were obtained from one parent
(usually the mother) in both SUD and MCC groups.
Design and procedure
In the SUD group, instruments were self-administered under the supervision of trained
staff (with Master’s or doctoral degrees in clinical psychology) within a month of the
patient’s referral to the Addictive Behaviors Unit. In the control group, questionnaires
were self-administered in groups on the premises of each participating school, under the
supervision of a clinical psychologist with a Master’s degree. The study was explained in
detail to parents and participants who gave written, informed consent before entering
the study. The evaluation protocol was reviewed and approved by the hospital ethics
committee (Ethics committee’s reference number: 5098).
Statistical analysis
The Student’s t test was applied to calculate differences in age between the cases and
controls. Analysis of covariance (ANCOVA) was used to identify differences in quantitative
variables between groups, with age and number of comorbid diagnoses as covariates. The
Chi-squared test and the Fisher exact test were used to compare categorical variables. In
addition, effect sizes were calculated for the differences between groups. Bivariate partial
correlation coefficients were calculated for age at onset of drug use, level of drug use,
internalizing/externalizing psychopathology, and scores on the PSY-5 scales and their
facets. Each PSY-5 scale was controlled by the other four remaining PSY-5 scales. We have
also performed this analysis for each facet controlling the other remaining facets. Finally,
binary logistic regression was used to identify the PSY-5 scales and the facets that best
predicted membership of a given group.
RESULTS
Descriptive statistics of both groups
Seventy-four SUD cases were included in the final analyses. All met the criteria for
SUD according DSM-IV criteria and completed the assessment protocol (mean age,
16.4 years, standard deviation [SD], 0.85, range 15–18 years; 53% male). Eleven percent
of participants show a SUD without any comorbid diagnosis. Most participants (89%)
had one or more comorbid clinical disorder, including conduct disorder or oppositional
defiant disorder (40.5%; n= 30), attention deficit hyperactivity disorder (17.6%; n= 13),
eating disorder (14.8%; n = 11), adjustment disorder (12.1%; n = 9), non-affective
psychotic disorder (10.8%; n = 8), anxiety disorder (9.4%; n = 7), and mood disorder
(6.8%; n = 5). In terms of Axis II disorders, 16 (21.6%) adolescents met the criteria for at
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least one personality disorder. Note that the total percentage is more than 100%, due to
cases with multiple diagnoses.
The MCC group comprised 74 adolescents (mean age, 16.0 years [SD = 0.91], range
15–18 years; 53% male) extracted from a representative community group (n = 117).
MCC were matched with SUD patients by gender. There were no significant differences
between the initial community sample and the MCC group with respect to the PSY-5 scales
and their facets, behavioral or emotional symptoms, age at first drug use, or patterns of
levels of use. The MCC group was therefore representative of the overall community group.
Differences between SUD cases and controls in PSY-5
Table 1 shows the sociodemographic and clinical data for the SUD and MCC groups,
as well as the differences between them. The ANCOVA took age and comorbidity as
covariates. The raw score on each of the PSY-5 scales differed significantly between groups,
with the score on the Disconstraint scale showing the greatest difference and a large
effect size. Almost all the facets of PSY-5 scales also showed significant between-group
differences, with the exception of the Grandiosity/Indignation and Low Sociability
facets. The two groups also differed in the T scores for internalizing and externalizing
psychopathology in the CBCL, as well as in the percentages for different levels of substance
use (tobacco, alcohol, cannabis, and other drugs). Age at onset of substance use was
significantly earlier in the SUD group, although the effect size was moderate-low.
Figure 1 shows differences among the PSY-5 scales between groups (MCC vs. SUD) by
gender. The gray discontinuous threshold represents the mean raw score for PSY-5 scales
found in a previous clinical study with adolescents (Stokes et al., 2009). In the present
study, gender differences were only found on the Negative Emotionality scale, with females
scoring higher in both groups (p < .004 for MCC and p < .001 for SUD). However, no
significant interaction (F = 3.016; p = .080) was found between gender and group. The
largest between-group gender difference was found with the Disconstraint scale (p < .001
for both genders).
PSY-5 and age at onset of drug use
In Table 2, the MCC group showed significant partial correlations for age at onset of
alcohol use related to scores on the Discontraint scale, and significant correlations for age
at onset of cannabis drug use, mainly associated with the Delinquent attitudes facet. The
analysis for the SUD group revealed only one significant correlation between Disconstraint
scale and early age of cannabis use. The Delinquent Attitudes facet was associated with an
early onset of tobacco, cannabis and other drug use. Also Hostility and Low Sociability
facets were associated with early onset of other type of drug use.
PSY-5 and level of drug use
Also in Table 2, inside the MCC group regarding the level of drug use, the Disconstraint
scale was related to high level of cannabis and alcohol use. The Hostility facet was related to
tobacco and other drugs. Psychotic Beliefs was associated with a high level of cannabis and
other drug use. The Delinquent Attitudes facet was related to tobacco, alcohol, cannabis
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Table 1 Descriptive and differences between groups with respect to Personality Psychopathology Five
scales and facets, internalizing/externalizing symptoms, age at onset, and level of use for each drug.
Variables SUD MCC
Socio-demographic and
clinical variables
(n= 74) (n= 74) SUD vs. MCC
t(p)
Effect
size
Sex: n boys/n girls 39/35 39/35
Agea M (SD) 16.38 (0.85) 16.00 (0.91) −2.611 (.010)*
PSY-5 scales1 M (SD) M (SD) F (p) h2p
Aggressivenessc 9.26 (3.97) 6.84 (3.59) 6.16 (.001)** 0.11
Psychoticismc 3.34 (2.60) 1.81 (2.11) 5.17 (.002)** 0.10
Disconstraintc 12.77 (4.52) 6.46 (3.48) 30.72 (<.001)*** 0.39
Introversionc 7.65 (4.04) 5.84 (4.26) 4.09 (.008)** 0.08
Negative Emotionality/Neuroticismc 12.05 (4.46) 10.24 (3.90) 4.03 (.009)** 0.08
Facets1
Hostilityc 6.27 (3.02) 3.70 (2.77) 9.98 (<.001)*** 0.17
Grandiosity/Indignationc 2.99 (1.50) 3.14 (1.63) 2.22 (.089) 0.04
Psychotic Beliefs/Experiencesc 1.69 (1.73) 0.69 (1.40) 5.19 (.002)** 0.10
Odd Mentationc 1.65 (1.23) 1.12 (1.08) 3.62 (.015)* 0.07
Delinquent Attitudesc 9.36 (3.34) 4.58 (2.43) 33.25 (<.001)*** 0.41
Norm Violationc 3.41 (1.63) 1.88 (1.39) 13.67 (<.001)*** 0.22
Low Drive/Expectationsc 4.39 (2.61) 2.85 (2.00) 7.65 (<.001)*** 0.13
Low Sociabilityc 3.32 (2.10) 2.99 (2.95) 0.72 (.540) 0.02
CBCL symptoms2
Internalizingc 64.64 (14.43) 51.18 (9.69) 15.04 (<.001)*** 0.27
Externalizingc 65.58 (10.35) 50.18 (8.52) 28.72 (<.001)*** 0.39
Age at onset
Tobaccoc 13.48 (1.11) 13.97 (1.44) 1.36 (.261) 0.04
Alcoholc 13.81 (0.89) 14.38 (1.24) 3.78 (.012)* 0.08
Cannabisc 13.86 (1.30) 14.74 (0.96) 3.24 (.026)* 0.09
Other drugs (cocaine, amphetamines, etc.)c 15.43 (1.17) 16.33 (0.57) 4.80 (.008)** 0.13
Drug use level
Tobacco N(%) N(%) χ2(p) φ
No Useb 0 (0%) 42 (57%) 57.74 (<.001)*** 1.17
Use without problemsb 12 (17%) 21 (28%) 1.882 (.170) 0.23
Risky substance useb 62 (83%) 11 (15%) 35.63 (<.001)*** 0.69
Alcohol
No Useb 3 (4%) 27 (37%) 19.20 (<.001)*** 0.80
Use without problemsb 34 (46%) 41 (55%) 0.653 (.419) 0.09
Risky substance useb 37 (50%) 6 (8%) 22.35 (<.001)*** 0.72
Cannabis
No Useb 0 (0%) 54 (73%) 84.32(<.001)*** 1.24
Use without problemsb 14 (19%) 18 (24%) 0.50 (.480) 0.12
Risky substance useb 60 (81%) 2 (3%) 54.26 (<.001)*** 0.93
(continued on next page)
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Table 1 (continued)
Other drugs (cocaine, amphetamines, etc.) N(%) N(%) χ2(p) φ
No Useb 38 (52%) 72 (97%) 10.56 (.001)** 0.30
Use without problemsb 13 (18%) 2 (3%) 8.07 (.005)** 0.73
Risky substance useb 23 (30%) 0 (0%) 24.73(<.001)*** 1.03
Notes.
* p< .05.
** p< .010.
*** p< .001.
a Student’s t-test (df = 146).
b Chi-squared and Fisher’s exact test (df = 1).
c ANCOVA after controlling for age and comorbidity (df = 3).
1 Raw scores.
2 T scores.
Data in bold face indicate a moderate-large effect size h2p > 0.14 and φ > 0.50.
PSY-5, Personality Psychopathology Five; CBCL, Child Behavior Checklist; SUD, Substance Use Disorders; MCC,
Matched community control; SUP, substance use problems.
Figure 1 Dimensional raw scores of PSY-5 scales according to gender and type of group.
and other drug use. Low Drive/Expectations was associated with tobacco and alcohol
use and Low sociability was associated only with the level of alcohol use. In contrast, in
SUD group the level of drug use was positively correlated with, the Disconstraint scale for
alcohol, and Negative Emotionality scale for other drugs. The Delinquent Attitudes facet
was correlated with the level of cannabis. Other drugs level correlates positively with Low
Drive/Expectations and negatively with Low Sociability.
PSY-5 and behavioral or emotional symptoms
Internalizing symptoms scale of the CBCL in both MCC and SUD groups was related to
the Introversion scale, specifically with Low Drive/Expectations facet (Table 2). However,
externalizing symptoms measured by the CBCL was not associated with any scale or facet
of the PSY-5. These results partially validate the phenomenology of the PSY-5 scales with
respect to Achenbach’s model of psychopathology symptoms.
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Table 2 Partial correlations in the matched community control group and Substance Use Disorder group for PSY-5 scales and facets with respect
to age at onset, level of drug use, and symptoms (controlling personality scales or facets, respectively).
PSY-5 scales and facets Age at onset Drug use level Symptoms
TOB AH CAN OD TOB AH CAN OD INT EXT
Aggressiveness1 MCC −.01 .16 .14 – .15 .11 .11 .18 .03 .10
SUD −.01 .08 .17 .38 −.01 −.03 −.07 .01 −.03 .02
Psychoticism1 MCC .03 −.16 −.21 – −.08 −.06 −.11 −.18 .10 −.01
SUD .09 −.06 .21 −.04 .06 .00 .04 −.07 −.04 −.14
Disconstraint1 MCC −.25 −.31* −.33 – .17 .35** .44*** .13 −.10 .08
SUD −.18 −.03 −.29* −.16 .19 .28* .22 .19 −.08 .05
Introversion1 MCC −.26 −.14 −.16 – −.06 −.09 −.06 −.05 .23* −.01
SUD −.07 .02 −.06 −.21 .02 −.07 .13 −.01 .37** .06
Negative Emotionality1 MCC .26 .05 −.11 – .15 .11 .01 .11 .08 .15
SUD −.03 −.09 −.11 .01 .18 .20 .22 .27* .21 .22
Hostility2 MCC .17 .18 .13 – .24* .12 .13 .27* −.08 .13
SUD −.10 −.03 .09 −.54** −.02 .07 −.09 .03 −.16 .06
Grandiosity/Indignation2 MCC −.08 .06 −.07 – .09 .15 .11 .10 .11 .00
SUD .06 .05 .04 −.26 −.02 −.08 .13 −.06 .17 −.09
Psychotic Beliefs/Experiences2 MCC .19 −.16 −.34 – −.05 −.12 .24* .28* .16 .08
SUD .16 −.10 .21 −.01 .03 −.01 .04 −.08 −.13 −.02
Odd Mentation2 MCC −.08 −.02 .06 – −.04 .08 .12 .08 .00 −.03
SUD −.10 .01 −.01 .12 .11 .07 .05 .14 .15 −.04
Delinquent Attitudes2 MCC .02 −.18 −.57** – .25* .33** .40** .25* −.16 −.07
SUD −.32* −.14 −.39** −.42* −.13 .21 .32** .18 −.05 .06
Norm Violation2 MCC −.35 −.14 .35 – −.15 −.02 −.01 −.20 .09 .15
SUD .20 .14 .16 .15 −.01 .06 −.14 .05 −.09 .17
Low Drive/Expectations2 MCC .17 −.04 −.04 – .25* .28* .21 .08 .23* .21
SUD −.01 .08 −.04 −.05 .21 −.01 .12 .26* .39** .21
Low Sociability2 MCC −.26 −.08 .15 – −.07 −.27* −.20 −.04 .01 −.21
SUD −.06 −.07 −.07 −.51* −.20 −.06 .12 −.29* .16 −.18
Notes.
* p< .05.
** p< .010.
*** p< .001.
Data in bold face indicate a significant difference.
1 Bivariate partial correlations; partial coefficients represent relationship between (age, level and symptoms) and PSY-5 scales with remaiming PSY-5 scales as covariates.
2 Bivariate partial correlations; partial coefficients represent relationship between (age, level and symptoms) and PSY-5 facets with remaiming PSY-5 facets as covariates
TOB, Tobacco; AH, Alcohol; CAN, Cannabis; OD, Other drugs; INT, Internalizing; EXT, Externalizing; MCC, Matched Community Control group; SUD, Substance Use
Disorder group.
Note: in data of Age onset there are different number of subjects (between MCC and SUD groups and inside the different type of substance), for this reason the
correlations have different magnitude on their significance.
The predictive value of PSY-5 scales for identifying SUD
In the logistic regression models, we took the groups (SUD vs. MCC) as the dependent
variable, and the PSY-5 scales (controlling for age) as independent variables. The results
in Table 3 correspond to the only personality psychopathology scale that was related to
membership of the SUD group, namely Disconstraint (OR = 1.44;p < .001). Subsequent
analysis of its facets revealed that Delinquent Attitudes explained most of the group
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Table 3 Predictive values of the Disconstraint scale, the Delinquent Attitudes facet, and the patholog-
ical Disconstraint condition in relation to membership of the SUD group.
Variable OR 95% CI Hit rate
Raw score Disconstraint scalea 1.44*** 1.28–1.61 79.1%
Raw score Delinquent Attitudes facetb 1.73*** 1.44–2.06 79.7%
Pathological Disconstraint conditionc 24.40*** 7.03–85.13 74.3%
Notes.
CI, confidence interval; OR, Odds Ratio; SUD, substance use disorder.
a For overall adjusted model (age), χ2 = 71.52, df = 2, p< 0.001; Nagelkerke R2 = 0.51.
b For overall adjusted model (age), χ2 = 78.07, df = 2, p< 0.001; Nagelkerke R2 = 0.55.
c For overall adjusted model (age), χ2 = 51.70, df = 2, p< 0.001; Nagelkerke R2 = 0.39.
* p< .050.
** p< .010.
*** p≤ .001.
membership (OR = 1.73;p < .001), and was an even better predictor than the broad
Disconstraint scale. We then constructed a binary variable, based on raw cut-offs of≥14 in
males and≥12 in females, which were indicative of a pathological Disconstraint condition
(these scores represent T scores over 60, according to the clinical manuals of the MMPI-A
in a US sample). This analysis indicated that the pathological Disconstraint condition
achieved a higher odds ratio (OR = 24.4;p < .001) than the raw scores of either the
Disconstraint or the Delinquent Attitudes scales/facets.
DISCUSSION
This study is the first to analyze the PSY-5 model of personality psychopathology in a
sample of Spanish adolescents that included clinical outpatients with SUD and matched
community controls. Significant differences between groups (SUD vs. MCC) were
observed on all the PSY-5 scales and on many of their facets, as well as in relation to
internalizing and externalizing symptoms and several levels of substance use.
The relationship between PSY-5 personality traits (adolescent information), and
internalizing or externalizing symptoms of the CBCL (parent information), showed some
of the expected patterns in both groups. Internalizing symptoms were associated with
the Introversion scale specifically with Low Drive/Expectations facet. Paradoxically, the
expected relationship regarding externalizing symptoms and PSY-5 scales Disconstraint
and Aggressiveness were not supported neither in SUD nor in MCC group.
Our results partially confirm previous findings with regard to psychometric properties
when applying the PSY-5 model to both adults (Bagby et al., 2008) and adolescents
(Bolinskey et al., 2004) or relationships with internalizing symptoms in relation to
Introversion PSY-5 scale (Veltri et al., 2009). We also partially replicated the observation
that adolescents with SUD score higher on all PSY-5 scales and on many of their facets
(Stokes et al., 2009). Additionally, in the MCC group we observed a stronger relationship
between the Disconstraint scale and an earlier and more intense use of alcohol and only a
more intense use of cannabis. However, in the SUD sample, the Disconstraint is associated
with higher use of alcohol and earlier age of onset of cannabis. On the other hand, the
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Negative Emotionality scale showed some interesting associations mainly with higher
use of other type of drugs, which highlights the importance of internalizing symptoms
(Hussong et al., 2011), and negative emotionality (Elkins et al., 2006) in the development
of SUD in adolescents. Previous studies have reported a high prevalence of psychiatric
comorbidity among adolescent patients with SUD (Couwenbergh et al., 2006; Hawkins,
2009; Magallo´n-Neri et al., 2012), mainly in combination with conduct disorder and
other disruptive behavior disorders (Hawkins, 2009), but it is also relevant with affective
disorders, specially in girls, as suggested by Dı´az et al. (2011).
It is important to obtain evidence for the external validity of the PSY-5 adolescent
scales. In particular, it is important to discriminate disruptive behaviors between the
Disconstraint scale and other scales that assess externalizing symptoms, drug use, and
sexual acting-out as rated through clinical records (McNulty et al., 1997; Stokes et al., 2009).
In our study, some relationships are moderately sustained, such as those for early age at
first alcohol use, and higher tobacco, alcohol, and cannabis use in the MCC group. In the
community group, the Disconstraint scale could be an indicator of risk for the level of drug
use. Two findings merit particular attention here. First, the Delinquent Attitudes facet of
the Disconstraint scale was associated with the level of any substance use in MCC group
and specifically with cannabis in SUD group. Second, the Negative Emotionality scale was
related to the level of use for other drugs.
In regard to substance use onset, some interesting relations with the PSY-5 scales
emerge. For instance, one of our hypotheses, i.e., that early substance onset may be related
to the Disconstraint scale, is partially ratified, especially in regard to early alcohol use in our
non-clinical sample, as previous studies have shown (Chassin, Pitts & Prost, 2002; Iacono,
Malone & McGue, 2008; Tarter et al., 2003), and early cannabis use in SUD group. The
Disconstraint facet Delinquent Attitudes was associated with an early onset of cannabis
use in the MCC group and early onset of tobacco and cannabis and other drug use in the
SUD group. Although we expected clearer signs of the association of the Disconstraint
scale with early substance use, the evidence is that Delinquent Attitudes is the most
specific facet in the PSY-5 model for detecting problems related to early substance use
in adolescence. Also, it is relevant to remark that Hostility and Low Sociability are related
with early onset of other type of drugs. On the other hand, Negative Emotionality seems
to be related to substance use associated with a component of emotional dysregulation,
psychological discomfort and the self-medication mechanism for mitigation, escape
or coping with problems related to this discomfort (Baker et al., 2004; Hawkins, 2009).
Due to the early onset of substance use, it is associated with a more severe course of
illness and higher odds of diverse risky behaviors (Castellanos-Ryan et al., 2014; Malmberg
et al., 2010). Some brief school-based coping skills interventions targeting personality risk
factors for adolescent substance use have been shown delay onset or early substance use
(Castellanos-Ryan & Conrod, 2011).
In regard to the level of substance use, it should be noted that the Delinquent Attitudes
facet was a consistent and specific indicator of higher usage levels in both groups. In the
control group, it indicated levels of tobacco, alcohol, cannabis use and other drugs, and in
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the SUD group it indicated higher cannabis use. This is important because, although the
Disconstraint domain explained a considerable proportion of the variance in problems
associated with drug use, and the pathological condition of this scale indicated a higher
risk of belonging to the SUD group, the Delinquent Attitudes facet may explain much of
the apparent relationship. A more in-depth study of this and other facets (i.e Low Drive
Expectations and Low Sociability) is therefore required to understand the true impact
of these behaviors in adolescents with SUD. This could help the future development of
preventive interventions for the adolescent community population that are based on
personality profiles and coping strategies (Castellanos-Ryan, O’Leary-Barrett & Conrod,
2013). These results support the use of PSY-5 to identify risk cases for SUD, as well as to
plan specific treatments tailored to individual personality styles of the patients (Hawkins,
2009; Hicks, Iacono & McGue, 2014; Magallo´n-Neri et al., 2012).
Although the MMPI-A is widely used inside clinical and forensic settings (Archer,
2005; Stokes et al., 2009; Veltri et al., 2014) and can help to obtain indicators of general
psychopathological disturbances in clinical patients (such as SUD) and community
samples (Bolinskey et al., 2004), due to its length it can be difficult to apply in certain
contexts, specially if patient motivation is low. For this reason, it is important to develop
shorter instruments in order to extract the essence of the PSY-5 model, without forgetting
the indicators of test internal reliability (L, F and K scales) which enable clinicians
to discern between profiles with some degree of simulation (fake-bad or fake-good).
In the present study, the PSY-5 model shows potential for developing screening or
phenotypic risk markers indicators associated with substance use abuse or dependence in
adolescents, especially if scores on the Disconstraint scale are high. Other scales i.e SURPS
(Castellanos-Ryan & Conrod, 2011; Woicik et al., 2009), specifically in a Spanish version
(Robles-Garc´ıa et al., 2014) may become important tools for daily clinical and research
practice in the applicability to identify personality pathology characteristics associated
with young people at risk for developing substance use problems.
Limitations and strengths
Several limitations should be considered when interpreting these results. First, we mostly
analyzed self-reported measures to assess psychopathology in the control group. However,
these types of instruments guaranteed confidentiality and contributed to the reliability
results when assessing psychopathology, personality and substance use in adolescents. A
more detailed assessment via structured clinical interviews would be preferable for the
analysis of personality psychopathology because, depending on the type and methodology
used for detection, the descriptions can lead to over- or under- estimations of their impact
(Magallo´n-Neri et al., 2014). Second, although the comparison groups were matched
for gender, it would have been desirable to consider more sociodemographic variables.
However, the study group characteristics did not allow this, and the influence of both
gender, age and number of comorbid diagnoses were controlled. The third limitation is the
lack of Spanish scales for the PSY-5 dimensional model. The fourth limitation is related to
categorization in some variables and the limited use of sophisticated SEM analyses due to
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restricted sample. Additionally, the transversal design of the study prevents the possibility
of analyzing if comorbid conditions are the cause or the consequence of substance use
related problems.This is an issue that is worth analyzing in future studies. Despite these
limitations, the current study has a number of strengths that have been highlighted; these
aspects that can be considered innovatory in our study or not treated in previous studies.
Some scales such as Disconstraint, and specifically the facet of delinquent attitudes, we
found to be useful for the screening of problems associated with SUD in adolescents. In
addition, this study is one of the few to use matched clinical and control groups instead of
exclusively concentrating on adolescent alcohol use. We also focused on tobacco, cannabis
and other drugs. Finally, a considerable strength of the study is that, to our knowledge,
this is the first study in a Spanish or Latino context in use the personality psychopathology
(PSY-5) model in adolescents to identify substance use risk, which is very close to the new
domains of the alternative DSM-5 model of personality pathology.
CONCLUSIONS
Although the present results are preliminary and need to be replicated in larger samples,
this study illustrates how a dimensional approach to personality pathology can be helpful
in the assessment of adolescents with respect to the risk for development of substance use
problems. This highlights the importance of careful and individualized assessments of
personality in adolescence.
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